Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Variations in novel cellular therapy products manufacturing.

Fontaine MJ, Selogie E, Stroncek D, McKenna D, Szczepiorkowski ZM, Takanashi M, Garritsen H, Girdlestone J, Reems JA; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.

Cytotherapy. 2020 Mar 26. pii: S1465-3249(20)30032-3. doi: 10.1016/j.jcyt.2020.01.012. [Epub ahead of print]

PMID:
32223996
2.

What's in Your CART? Clinical insights on challenges in mononuclear cell collection for CAR-T therapy.

Annen K, Zubair A, Schwartz E, Schwartz J, Szczepiorkowski ZM.

J Clin Apher. 2020 Mar 18. doi: 10.1002/jca.21776. [Epub ahead of print] No abstract available.

PMID:
32186782
3.

Plasma exchange for Alzheimer's disease Management by Albumin Replacement (AMBAR) trial: Study design and progress.

Boada M, López O, Núñez L, Szczepiorkowski ZM, Torres M, Grifols C, Páez A.

Alzheimers Dement (N Y). 2019 Feb 26;5:61-69. doi: 10.1016/j.trci.2019.01.001. eCollection 2019.

4.

Current practices for viability testing of cryopreserved cord blood products: an international survey by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.

Takanashi M, Selogie E, Reems JA, Stroncek D, Fontaine MJ, Girdlestone J, Garritsen HSP, Young P, McKenna DH, Szczepiorkowski ZM; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.

Transfusion. 2018 Sep;58(9):2184-2191. doi: 10.1111/trf.14777.

PMID:
30204955
5.

Safety and efficacy of cryopreserved platelets in bleeding patients with thrombocytopenia.

Slichter SJ, Dumont LJ, Cancelas JA, Jones M, Gernsheimer TB, Szczepiorkowski ZM, Dunbar NM, Prakash G, Medlin S, Rugg N, Kinne B, Macdonald VW, Housler G, Valiyaveettil M, Hmel P, Ransom JH.

Transfusion. 2018 Sep;58(9):2129-2138. doi: 10.1111/trf.14780.

PMID:
30204953
6.

Assessing the risk of Babesia to the United States blood supply using a risk-based decision-making approach: Report of AABB's Ad Hoc Babesia Policy Working Group (original report).

Ward SJ, Stramer SL, Szczepiorkowski ZM.

Transfusion. 2018 Aug;58(8):1916-1923. doi: 10.1111/trf.14912. Epub 2018 Sep 4.

PMID:
30180272
7.

Bacterial screening of apheresis platelets with a rapid test: a 113-month single center experience.

Ruby KN, Thomasson RR, Szczepiorkowski ZM, Dunbar NM.

Transfusion. 2018 Jul;58(7):1665-1669. doi: 10.1111/trf.14629. Epub 2018 Apr 17.

PMID:
29664170
8.

Apheresis buffy coat collection without photoactivation has no effect on apoptosis, cell proliferation, and total viability of mononuclear cells collected using photopheresis systems.

Szczepiorkowski ZM, Burnett CA, Dumont LJ, Abhyankar SH.

Transfusion. 2018 Apr;58(4):943-950. doi: 10.1111/trf.14532. Epub 2018 Feb 16.

PMID:
29451308
9.

Routine use of Day 6 and Day 7 platelets with rapid testing: two hospitals assess impact 1 year after implementation.

Harm SK, Szczepiorkowski ZM, Dunbar NM.

Transfusion. 2018 Apr;58(4):938-942. doi: 10.1111/trf.14473. Epub 2018 Jan 14.

PMID:
29332317
10.

Therapeutic plasma exchange for thrombotic thrombocytopenic purpura with refractory thrombocytopenia.

Maloney N, Martin I, Szczepiorkowski ZM, Dunbar NM.

J Clin Apher. 2018 Jun;33(3):436-438. doi: 10.1002/jca.21612. Epub 2017 Dec 22.

PMID:
29270999
11.

Optimal Storage Conditions for Apheresis Research (OSCAR): a Biomedical Excellence for Safer Transfusion (BEST) Collaborative study.

Gniadek TJ, Garritsen HSP, Stroncek D, Szczepiorkowski ZM, McKenna DH; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.

Transfusion. 2018 Feb;58(2):461-469. doi: 10.1111/trf.14429. Epub 2017 Dec 6.

PMID:
29210068
12.

Extracorporeal photopheresis for graft versus host disease: Identifying a clinical pathway and associated resource utilization.

Yerrabothala S, Talebian L, Klinker K, Hickman J, Hill JM, Hayes C, Lowrey C, Szczepiorkowski ZM, Meehan KR.

J Clin Apher. 2018 Jun;33(3):310-315. doi: 10.1002/jca.21606. Epub 2017 Nov 28.

PMID:
29193271
13.

A Study of the Pharmacokinetic Properties and the In Vivo Kinetics of Erythrocytes Loaded With Dexamethasone Sodium Phosphate in Healthy Volunteers.

Coker SA, Szczepiorkowski ZM, Siegel AH, Ferrari A, Mambrini G, Anand R, Hartman RD, Benatti L, Dumont LJ.

Transfus Med Rev. 2018 Apr;32(2):102-110. doi: 10.1016/j.tmrv.2017.09.001. Epub 2017 Sep 19.

PMID:
29031409
14.

The first reported case of concurrent trimethoprim-sulfamethoxazole-induced immune hemolytic anemia and thrombocytopenia.

Linnik YA, Tsui EW, Martin IW, Szczepiorkowski ZM, Denomme GA, Gottschall JL, Hill JM Jr, Dunbar NM.

Transfusion. 2017 Dec;57(12):2937-2941. doi: 10.1111/trf.14315. Epub 2017 Sep 14.

PMID:
28905389
15.

Transfusion Service Observations: Red Blood Cell Surname-Antibody Pairings.

Alquist CR, Szczepiorkowski ZM.

Ochsner J. 2017 Summer;17(2):134-135. No abstract available.

16.

Clinical methods of cryopreservation for donor lymphocyte infusions vary in their ability to preserve functional T-cell subpopulations.

Worsham DN, Reems JA, Szczepiorkowski ZM, McKenna DH, Leemhuis T, Mathew AJ, Cancelas JA; Biomedical Excellence for Safer Transfusion (BEST) Collaborative Group.

Transfusion. 2017 Jun;57(6):1555-1565. doi: 10.1111/trf.14112. Epub 2017 Apr 28.

PMID:
28453219
17.

Red blood cell metabolic responses to refrigerated storage, rejuvenation, and frozen storage.

D'Alessandro A, Gray AD, Szczepiorkowski ZM, Hansen K, Herschel LH, Dumont LJ.

Transfusion. 2017 Apr;57(4):1019-1030. doi: 10.1111/trf.14034. Epub 2017 Mar 10.

PMID:
28295356
18.

Blood component transfusion and wastage rates in the setting of massive transfusion in three regional trauma centers.

Dunbar NM, Olson NJ, Szczepiorkowski ZM, Martin ED, Tysarcyk RM, Triulzi DJ, Alarcon LH, Yazer MH.

Transfusion. 2017 Jan;57(1):45-52. doi: 10.1111/trf.13880. Epub 2016 Oct 23.

PMID:
27774614
19.

Babesia parasitemia rebound after red blood cell exchange.

Alquist CR, Szczepiorkowski ZM, Dunbar N.

J Clin Apher. 2017 Aug;32(4):276-278. doi: 10.1002/jca.21492. Epub 2016 Sep 1.

PMID:
27583822
20.

Extracorporeal photopheresis practice patterns: An international survey by the ASFA ECP subcommittee.

Dunbar NM, Raval JS, Johnson A, Abikoff CM, Adamski J, Cooling LL, Grossman B, Kim HC, Marques MB, Morgan S, Schmidt AE, Sloan SR, Su LL, Szczepiorkowski ZM, West FB, Wong E, Schneiderman J.

J Clin Apher. 2017 Aug;32(4):215-223. doi: 10.1002/jca.21486. Epub 2016 Jul 21.

21.

Highlighting oft-overlooked granulocyte-colony-stimulating factor kinetics.

Raasch Alquist C, Root L, Dunbar N, Szczepiorkowski ZM.

Transfusion. 2016 Jun;56(6):1484-5. doi: 10.1111/trf.13604. No abstract available.

PMID:
27264014
22.

Primum non confundere: whole blood versus apheresis platelet debate continues.

Szczepiorkowski ZM, McCullough J, Triulzi DJ.

Transfusion. 2016 Jun;56(6):1254-7. doi: 10.1111/trf.13642. No abstract available.

PMID:
27264009
23.

How do we implement Day 6 and Day 7 platelets at a hospital-based transfusion service?

Dunbar NM, Dumont LJ, Szczepiorkowski ZM.

Transfusion. 2016 Jun;56(6):1262-6. doi: 10.1111/trf.13577. Epub 2016 Mar 28.

PMID:
27018564
24.

CO2 -dependent metabolic modulation in red blood cells stored under anaerobic conditions.

Dumont LJ, D'Alessandro A, Szczepiorkowski ZM, Yoshida T.

Transfusion. 2016 Feb;56(2):392-403. doi: 10.1111/trf.13364. Epub 2015 Oct 19.

25.

Rapid ADAMTS13 availability impacts treatment for microangiopathic hemolytic anemia and thrombocytopenia.

Martin IW, Katus MC, Martin CL, Szczepiorkowski ZM, Gorham JD, Dunbar NM.

J Clin Apher. 2016 Oct;31(5):419-22. doi: 10.1002/jca.21419. Epub 2015 Aug 31.

PMID:
26332753
26.

Red blood cell storage in additive solution-7 preserves energy and redox metabolism: a metabolomics approach.

D'Alessandro A, Nemkov T, Hansen KC, Szczepiorkowski ZM, Dumont LJ.

Transfusion. 2015 Dec;55(12):2955-66. doi: 10.1111/trf.13253. Epub 2015 Aug 14.

27.

How do we utilize a transfusion safety officer?

Dunbar NM, Szczepiorkowski ZM.

Transfusion. 2015 Sep;55(9):2064-8. doi: 10.1111/trf.13184. Epub 2015 May 30. Review.

PMID:
26033515
28.

Therapeutic plasma exchange as a steroid-sparing therapy in a patient with limbic encephalitis due to antibodies to voltage-gated potassium channels.

Martin IW, Martin CL, Dunbar NM, Lee SL, Szczepiorkowski ZM.

J Clin Apher. 2016 Feb;31(1):63-5. doi: 10.1002/jca.21395. Epub 2015 Apr 7.

PMID:
25851808
29.

Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions.

Dunbar NM, Katus MC, Freeman CM, Szczepiorkowski ZM.

Transfusion. 2015 Aug;55(8):1882-8. doi: 10.1111/trf.13077. Epub 2015 Mar 11.

PMID:
25757728
30.

Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital.

Weber LL, Dunbar NM, Meehan KR, Szczepiorkowski ZM, Lansigan F.

J Clin Apher. 2015 Dec;30(6):359-63. doi: 10.1002/jca.21382. Epub 2015 Feb 17.

PMID:
25691106
31.

National Institutes of Health State of the Science Symposium in Therapeutic Apheresis: scientific opportunities in extracorporeal photopheresis.

Ratcliffe N, Dunbar NM, Adamski J, Couriel D, Edelson R, Kitko CL, Levine JE, Morgan S, Schneiderman J, Sloan S, Wu Y, Szczepiorkowski ZM, Cooling L; American Society for Apheresis.

Transfus Med Rev. 2015 Jan;29(1):62-70. doi: 10.1016/j.tmrv.2014.09.004. Epub 2014 Oct 15. Review.

PMID:
25459074
32.

Hardwiring patient blood management: harnessing information technology to optimize transfusion practice.

Dunbar NM, Szczepiorkowski ZM.

Curr Opin Hematol. 2014 Nov;21(6):515-20. doi: 10.1097/MOH.0000000000000092. Review.

PMID:
25295746
33.

Overnight, room temperature hold of whole blood followed by 42-day storage of red blood cells in additive solution-7.

Dumont LJ, Cancelas JA, Maes LA, Rugg N, Whitley P, Herschel L, Siegal AH, Szczepiorkowski ZM, Hess JR, Zia M.

Transfusion. 2015 Mar;55(3):485-90. doi: 10.1111/trf.12868. Epub 2014 Sep 19.

PMID:
25234026
34.

The bioequivalence of frozen plasma prepared from whole blood held overnight at room temperature compared to fresh-frozen plasma prepared within eight hours of collection.

Dumont LJ, Cancelas JA, Maes LA, Rugg N, Whitley P, Herschel L, Siegel AH, Szczepiorkowski ZM, Hess JR, Zia M.

Transfusion. 2015 Mar;55(3):476-84. doi: 10.1111/trf.12864. Epub 2014 Sep 19.

PMID:
25233805
35.

The top clinical trial opportunities in therapeutic apheresis and neurology.

Morgan SM, Shaz BH, Pavenski K, Meyer EK, Delaney M, Szczepiorkowski ZM.

J Clin Apher. 2014 Dec;29(6):331-5. doi: 10.1002/jca.21339. Epub 2014 Jun 5.

PMID:
24899381
36.

Significant reduction in red blood cell transfusions in a general hospital after successful implementation of a restrictive transfusion policy supported by prospective computerized order auditing.

Yerrabothala S, Desrosiers KP, Szczepiorkowski ZM, Dunbar NM.

Transfusion. 2014 Oct;54(10 Pt 2):2640-5. doi: 10.1111/trf.12627. Epub 2014 Mar 27.

PMID:
24673396
37.

Safety of platelet transfusion: past, present and future.

Katus MC, Szczepiorkowski ZM, Dumont LJ, Dunbar NM.

Vox Sang. 2014 Aug;107(2):103-13. doi: 10.1111/vox.12146. Epub 2014 Mar 20. Review.

PMID:
24650183
38.

Transfusion guidelines: when to transfuse.

Szczepiorkowski ZM, Dunbar NM.

Hematology Am Soc Hematol Educ Program. 2013;2013:638-44. doi: 10.1182/asheducation-2013.1.638. Review.

PMID:
24319244
39.

Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research.

Sarode R, Bandarenko N, Brecher ME, Kiss JE, Marques MB, Szczepiorkowski ZM, Winters JL.

J Clin Apher. 2014 Jun;29(3):148-67. doi: 10.1002/jca.21302. Epub 2013 Oct 17.

40.

American society for apheresis guidelines support use of red cell exchange transfusion for severe malaria with high parasitemia.

Shaz BH, Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Szczepiorkowski ZM, Williams ME, Wu Y, Linenberger ML.

Clin Infect Dis. 2014 Jan;58(2):302-3. doi: 10.1093/cid/cit662. Epub 2013 Oct 2. No abstract available.

PMID:
24092801
41.

Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue.

Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, Szczepiorkowski ZM, Williams ME, Wu Y, Shaz BH.

J Clin Apher. 2013 Jul;28(3):145-284. doi: 10.1002/jca.21276.

PMID:
23868759
42.

Balancing risk and benefit: maintenance of a thawed Group A plasma inventory for trauma patients requiring massive transfusion.

Mehr CR, Gupta R, von Recklinghausen FM, Szczepiorkowski ZM, Dunbar NM.

J Trauma Acute Care Surg. 2013 Jun;74(6):1425-31. doi: 10.1097/TA.0b013e31828b813e.

PMID:
23694868
43.

Pooled platelet concentrates or apheresis platelets?

Dumont LJ, Szczepiorkowski ZM.

N Engl J Med. 2013 May 9;368(19):1848-9. doi: 10.1056/NEJMc1302634. No abstract available.

PMID:
23656664
44.

Current practices and prospects for standardization of the hematopoietic colony-forming unit assay: a report by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.

Pamphilon D, Selogie E, McKenna D, Cancelas-Peres JA, Szczepiorkowski ZM, Sacher R, McMannis J, Eichler H, Garritsen H, Takanashi M, van de Watering L, Stroncek D, Reems JA.

Cytotherapy. 2013 Mar;15(3):255-62. doi: 10.1016/j.jcyt.2012.11.013.

45.

Refractory heparin induced thrombocytopenia with thrombosis (HITT) treated with therapeutic plasma exchange and rituximab as adjuvant therapy.

Schell AM, Petras M, Szczepiorkowski ZM, Ornstein DL.

Transfus Apher Sci. 2013 Oct;49(2):185-8. doi: 10.1016/j.transci.2013.01.007. Epub 2013 Feb 16.

PMID:
23419837
46.

Routine bacterial screening of apheresis platelets on Day 4 using a rapid test: a 4-year single-center experience.

Dunbar NM, Kreuter JD, Marx-Wood CR, Dumont LJ, Szczepiorkowski ZM.

Transfusion. 2013 Oct;53(10):2307-13. doi: 10.1111/trf.12083. Epub 2013 Jan 24.

PMID:
23347110
47.

Successful use of citrate anticoagulant with heparin bolus for excessive clotting during extracorporeal photopheresis.

Weber LL, Dunbar NM, Dumont LJ, Szczepiorkowski ZM.

Transfusion. 2012 Nov;52(11):2494-5. doi: 10.1111/j.1537-2995.2012.03846.x. No abstract available.

PMID:
23140434
48.

Retrograde patient blood flow and rouleaux preventing red blood cell transfusion.

Dunbar NM, Marx-Wood CR, Maynard KJ, Ng DP, Szczepiorkowski ZM, Dumont LJ.

Transfusion. 2012 Nov;52(11):2284. doi: 10.1111/j.1537-2995.2012.03601.x. No abstract available.

PMID:
23140428
49.

In vitro and in vivo quality of leukoreduced apheresis platelets stored in a new platelet additive solution.

Dumont LJ, Cancelas JA, Graminske S, Friedman KD, Vassallo RR, Whitley PH, Rugg N, Dumont DF, Herschel L, Siegal AH, Szczepiorkowski ZM, Fender L, Razatos A.

Transfusion. 2013 May;53(5):972-80. doi: 10.1111/j.1537-2995.2012.03841.x. Epub 2012 Aug 6.

PMID:
22882530
50.

Red blood cell alloantibodies: a 45-year historical review at a rural tertiary care center.

Petras ML, Leach MK, Szczepiorkowski ZM, Dunbar NM.

Transfusion. 2012 Jun;52(6):1380-2. doi: 10.1111/j.1537-2995.2012.03582.x. No abstract available.

PMID:
22686534

Supplemental Content

Loading ...
Support Center